ArticleCell reports2017

Cancer-Associated IDH1 Promotes Growth and Resistance to Targeted Therapies in the Absence of Mutation.

Andrea E Calvert et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.